Home Cart 0 Sign in  
X

[ CAS No. 13421-13-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 13421-13-1
Chemical Structure| 13421-13-1
Chemical Structure| 13421-13-1
Structure of 13421-13-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 13421-13-1 ]

Related Doc. of [ 13421-13-1 ]

Alternatived Products of [ 13421-13-1 ]

Product Details of [ 13421-13-1 ]

CAS No. :13421-13-1 MDL No. :MFCD00060676
Formula : C7H4ClIO2 Boiling Point : -
Linear Structure Formula :- InChI Key :LRRDANNSUCQNDU-UHFFFAOYSA-N
M.W : 282.46 Pubchem ID :139452
Synonyms :

Calculated chemistry of [ 13421-13-1 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 51.13
TPSA : 37.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.92 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.64
Log Po/w (XLOGP3) : 2.96
Log Po/w (WLOGP) : 2.64
Log Po/w (MLOGP) : 3.09
Log Po/w (SILICOS-IT) : 2.83
Consensus Log Po/w : 2.63

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -3.79
Solubility : 0.0454 mg/ml ; 0.000161 mol/l
Class : Soluble
Log S (Ali) : -3.41
Solubility : 0.111 mg/ml ; 0.000393 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.33
Solubility : 0.131 mg/ml ; 0.000465 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 1.71

Safety of [ 13421-13-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 13421-13-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 13421-13-1 ]
  • Downstream synthetic route of [ 13421-13-1 ]

[ 13421-13-1 ] Synthesis Path-Upstream   1~4

  • 1
  • [ 89-77-0 ]
  • [ 13421-13-1 ]
Reference: [1] Tetrahedron, 2006, vol. 62, # 4, p. 737 - 745
[2] Journal of the American Chemical Society, [3] Journal of the American Chemical Society, 2009, vol. 131, p. 251 - 262
[4] Patent: US2003/187014, 2003, A1,
[5] Collection of Czechoslovak Chemical Communications, 1968, vol. 33, # 6, p. 1852 - 1872
[6] Organic and Biomolecular Chemistry, 2014, vol. 12, # 27, p. 5031 - 5037
[7] Patent: WO2014/189370, 2014, A1, . Location in patent: Page/Page column 27
  • 2
  • [ 6280-88-2 ]
  • [ 13421-13-1 ]
Reference: [1] Collection of Czechoslovak Chemical Communications, 1968, vol. 33, # 6, p. 1852 - 1872
  • 3
  • [ 33184-48-4 ]
  • [ 13421-13-1 ]
Reference: [1] Gazzetta Chimica Italiana, 1941, vol. 71, p. 389,392
  • 4
  • [ 67-56-1 ]
  • [ 13421-13-1 ]
  • [ 181765-85-5 ]
YieldReaction ConditionsOperation in experiment
74% at 20℃; General procedure: To a stirred solution of the corresponding benzoic acid (1.0 equiv) in dry MeOH (2.0 mL per 1.0 mmol of benzoic acid) at 0° C. was added SOCl2 (2.0 equiv) dropwise. After addition, the reaction was allowed to stir at room temperature overnight. The crude reaction was concentrated in vacuo, quenched with water, and extracted with EtOAc. The combined organic layer was washed with saturated aqueous NaHCO3, dried over anhydrous Na2SO4, concentrated by rotary evaporation, and purified by column chromatography to give 21a-b.
Reference: [1] Antimicrobial Agents and Chemotherapy, 2016, vol. 60, # 7, p. 3980 - 3987
[2] Patent: US2015/105351, 2015, A1, . Location in patent: Paragraph 0451
[3] ACS Medicinal Chemistry Letters, 2014, vol. 5, # 11, p. 1259 - 1262
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 13421-13-1 ]

Aryls

Chemical Structure| 13421-00-6

[ 13421-00-6 ]

5-Chloro-2-iodobenzoic acid

Similarity: 0.98

Chemical Structure| 181765-85-5

[ 181765-85-5 ]

Methyl 4-chloro-2-iodobenzoate

Similarity: 0.92

Chemical Structure| 123278-03-5

[ 123278-03-5 ]

3-Chloro-2-iodobenzoic acid

Similarity: 0.92

Chemical Structure| 289039-82-3

[ 289039-82-3 ]

Methyl 5-chloro-2-iodobenzoate

Similarity: 0.91

Chemical Structure| 289039-25-4

[ 289039-25-4 ]

3-Chloro-5-iodobenzoic acid

Similarity: 0.89

Chlorides

Chemical Structure| 13421-00-6

[ 13421-00-6 ]

5-Chloro-2-iodobenzoic acid

Similarity: 0.98

Chemical Structure| 181765-85-5

[ 181765-85-5 ]

Methyl 4-chloro-2-iodobenzoate

Similarity: 0.92

Chemical Structure| 123278-03-5

[ 123278-03-5 ]

3-Chloro-2-iodobenzoic acid

Similarity: 0.92

Chemical Structure| 289039-82-3

[ 289039-82-3 ]

Methyl 5-chloro-2-iodobenzoate

Similarity: 0.91

Chemical Structure| 289039-25-4

[ 289039-25-4 ]

3-Chloro-5-iodobenzoic acid

Similarity: 0.89

Carboxylic Acids

Chemical Structure| 13421-00-6

[ 13421-00-6 ]

5-Chloro-2-iodobenzoic acid

Similarity: 0.98

Chemical Structure| 123278-03-5

[ 123278-03-5 ]

3-Chloro-2-iodobenzoic acid

Similarity: 0.92

Chemical Structure| 289039-25-4

[ 289039-25-4 ]

3-Chloro-5-iodobenzoic acid

Similarity: 0.89

Chemical Structure| 42860-04-8

[ 42860-04-8 ]

4-Chloro-3-iodobenzoic acid

Similarity: 0.86

Chemical Structure| 58123-72-1

[ 58123-72-1 ]

3-Chloro-4-iodobenzoic acid

Similarity: 0.84